Patents by Inventor Uwe Schönbeck

Uwe Schönbeck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NATRIURETIC FUSION PROTEINS
    Publication number: 20100310561
    Abstract: Natriuretic peptide fusion proteins comprising natriuretic peptides linked to antibody Fc domains, nucleic acid molecules encoding the fusion proteins disclosed herein, expression vectors expressing said fusion proteins, pharmaceutical compositions comprising said fusion proteins, and methods for their therapeutic use are disclosed.
    Type: Application
    Filed: June 3, 2008
    Publication date: December 9, 2010
    Applicants: BOEHRINGER INGELHEIM INTERNATIONAL GMBH, SYNTONIX PHARMACEUTICALS, INC.
    Inventors: Keith Canada, Uwe Schoenbeck, Eugene R. Hickey, Adam Mezo, Kevin McDonnell
  • Soluble CD40L(CD154) as a prognostic marker of atherosclerotic diseases
    Patent number: 7189518
    Abstract: This invention involves the new use of a diagnostic test to determine the risk of atherosclerotic diseases such as myocardial infarction and stroke, particularly among individuals with no signs or symptoms of current disease and among nonsmokers. Further, this invention involves the new use of a diagnostic test to assist physicians in determining which individuals at risk will preferentially benefit from certain treatments designed either to prevent first or recurrent myocardial infarctions and strokes, or to treat acute and chronic cardiovascular disorders. Methods for treatment also are described.
    Type: Grant
    Filed: November 5, 2002
    Date of Patent: March 13, 2007
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Uwe Schönbeck, Paul Ridker, Peter Libby